Worth reading
45Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
43
¥100 million (year-on-year increase in net sales)Wording
Definitive
How definitive the wording is.Contents of this document
Earnings presentationFirst quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥759 million+6.0%
Operating profit¥37 million+11.2%
Ordinary income¥41 million+25.0%
Net income¥31 million+23.5%
Selling, general and administrative expenses¥72 million
Gross Profit Margin
Rate14.4%
Year-on-year change+0.3 percentage points
Operating profit margin
Rate4.8%
Results for the three months of the current quarterRevenue was ¥75.9 billion, operating income was ¥3.7 billion, ordinary income was ¥4.1 billion, and net income attributable to owners of the parent was ¥3.1 billion.
Full-year earnings forecast
Net Sales
¥3,200 million
Operating profit
¥145 million
Profit attributable to owners of the parent
¥105 million
Textiles revenue
¥1,550 million
Chemicals revenue
¥1,645 million
Textiles operating profit
¥75 million
Chemicals operating profit
¥80 million
Other operating loss
¥-10 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales23.7%
Textiles revenue22.7%
Chemicals revenue24.5%
Operating profit25.2%
Textiles operating profit21.0%
Chemicals operating profit28.0%
Profit attributable to owners of the parent29.5%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Revenue and operating income are both progressing steadily against the full-year forecasts.Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Net SalesCapturing demand arising from heightened tensions in the Middle East; weaker yen
Gross profitPassing costs through to selling prices; maintaining profitability
Selling, general and administrative expensesContinue investing in human capital
Operating profitHigher revenue and margin improvement absorbed the increase in SG&A expenses
Ordinary incomeImprovement in foreign exchange gains and losses; increase in equity-method investment gains
Net incomeIncome taxes and other taxes: +¥300 million
New initiatives
- Advancing the basic policy of the medium-term management plan CIP2028: “Specialization × Globalization × Business Investment”
Key KPIsA metric the company considers important as a management benchmark.
- Equity ratio68.9 %Year on year against the same period last year+2.2 percentage points from the previous fiscal year-end
- ROE12 %Year on year against the same period last year-0.4 percentage points from the previous fiscal year-end
- ROIC10.3 %Year on year against the same period last year-0.8 percentage points from the previous fiscal year-end
- Overseas revenue ratio34 %Year on year against the same period last yearDown from 35% in the same period of the previous year
Segment results
Fibers
Net Sales
¥352 million
yoy+¥1.5 billion
Operating profit
¥16 million
yoyYear-on-year earnings decline
Chemicals
Net Sales
¥404 million
yoy+¥2.7 billion
Operating profit
¥22 million
yoyHigher income year on year
Other
Net Sales
¥3 million
Operating loss
¥-2 million
Medium-term management plan targets
The company is advancing the basic policy of the medium-term management plan, “Chori Innovation Plan 2028 (CIP2028),” centered on “Specialization × Globalization × Business Investment.” Specific targets are Not disclosed.Financial targets
Actual results were ROE of 12.0%, ROIC of 10.3%, and an equity ratio of 68.9%. Target values are Not disclosed.Annual Dividend
Annual¥171 per share
Breakdown
Interim85
End of period86
Payout ratio
Rate40.1 %
PolicyConsolidated payout ratio of at least 40% and DOE of at least 3.5%
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥759 million (YoY +6.0%) |
| Operating profit | ¥37 million (YoY +11.2%) |
| Ordinary income | ¥41 million (YoY +25.0%) |
| Net income | ¥31 million (YoY +23.5%) |
| Gross Profit Margin | Rate 14.4% / Year-on-year change +0.3 percentage points |
| Operating profit margin | Rate 4.8% / Year-on-year change Not disclosed |
| Selling, general and administrative expenses | ¥72 million |
| Results for the three months of the current quarter | Revenue was ¥75.9 billion, operating income was ¥3.7 billion, ordinary income was ¥4.1 billion, and net income attributable to owners of the parent was ¥3.1 billion. |
| Full-year earnings forecast | Net Sales ¥3,200 million / Operating profit ¥145 million / Profit attributable to owners of the parent ¥105 million / Textiles revenue ¥1,550 million / Chemicals revenue ¥1,645 million / Textiles operating profit ¥75 million / Chemicals operating profit ¥80 million / Other operating loss ¥-10 million |
| Progress against full-year forecast | Net Sales 23.7% / Textiles revenue 22.7% / Chemicals revenue 24.5% / Operating profit 25.2% / Textiles operating profit 21.0% / Chemicals operating profit 28.0% / Profit attributable to owners of the parent 29.5% |
| Self-assessment against the plan | Revenue and operating income are both progressing steadily against the full-year forecasts. |
| Segment results | Fibers Net Sales ¥352 million / Operating profit ¥16 million / Chemicals Net Sales ¥404 million / Operating profit ¥22 million / Other Net Sales ¥3 million / Operating loss ¥-2 million |
| Breakdown of Factors Affecting the Change | Net Sales Capturing demand arising from heightened tensions in the Middle East; weaker yen / Gross profit Passing costs through to selling prices; maintaining profitability / Selling, general and administrative expenses Continue investing in human capital / Operating profit Higher revenue and margin improvement absorbed the increase in SG&A expenses / Ordinary income Improvement in foreign exchange gains and losses; increase in equity-method investment gains / Net income Income taxes and other taxes: +¥300 million |
| Key KPIs | Indicator name Equity ratio / Value 68.9 % / Year on year against the same period last year +2.2 percentage points from the previous fiscal year-end, Indicator name ROE / Value 12 % / Year on year against the same period last year -0.4 percentage points from the previous fiscal year-end, Indicator name ROIC / Value 10.3 % / Year on year against the same period last year -0.8 percentage points from the previous fiscal year-end, Indicator name Overseas revenue ratio / Value 34 % / Year on year against the same period last year Down from 35% in the same period of the previous year |
| Medium-term management plan targets | The company is advancing the basic policy of the medium-term management plan, “Chori Innovation Plan 2028 (CIP2028),” centered on “Specialization × Globalization × Business Investment.” Specific targets are Not disclosed. |
| Financial targets | Actual results were ROE of 12.0%, ROIC of 10.3%, and an equity ratio of 68.9%. Target values are Not disclosed. |
| Annual Dividend | Annual ¥171 per share / Breakdown Interim 85 / End of period 86 |
| Payout ratio | Rate 40.1 % / Policy Consolidated payout ratio of at least 40% and DOE of at least 3.5% |
| New initiatives | Advancing the basic policy of the medium-term management plan CIP2028: “Specialization × Globalization × Business Investment” |
Items this document does not state (10)
Unit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The factors cited include capturing demand arising from heightened tensions in the Middle East, the weaker yen, passing higher procurement costs through to selling prices, and increased equity-method investment gains. Selling, general and administrative expenses increased due to continued investment in human capital.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.